First Horizon Pharma gestern fast -20% (Nasdaq) - 500 Beiträge pro Seite
eröffnet am 30.04.03 19:48:00 von
neuester Beitrag 30.04.03 22:07:41 von
neuester Beitrag 30.04.03 22:07:41 von
Beiträge: 7
ID: 727.088
ID: 727.088
Aufrufe heute: 0
Gesamt: 406
Gesamt: 406
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
gestern 18:21 | 294 | |
heute 03:11 | 238 | |
08.05.24, 11:56 | 236 | |
heute 00:02 | 196 | |
heute 03:06 | 186 | |
17.05.24, 19:20 | 177 | |
vor 59 Minuten | 168 | |
heute 02:00 | 162 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.704,42 | -0,18 | 186 | |||
2. | 4. | 6,5320 | -2,74 | 81 | |||
3. | 14. | 22,210 | -19,73 | 73 | |||
4. | 18. | 31,61 | +7,14 | 69 | |||
5. | 6. | 10,700 | +1,71 | 66 | |||
6. | 10. | 16,750 | +4,69 | 47 | |||
7. | 5. | 177,46 | +1,50 | 47 | |||
8. | 3. | 4,4000 | -5,17 | 42 |
Habe keine negativen Nachrichten gefunden, weiß jemand warum der Wert gestern - 20 % verloren hat. Ersuche um Antwort
du arme sau
Auf deine Antworten kann ich verzichten!!!!!!!!
abgezockt?
First Horizon sees results worse than estimates
TUESDAY, APRIL 29, 2003 9:55 AM
- Reuters U.S. Company News
(Recasts lead, adds stock price, details)
NEW YORK, April 29 (Reuters) - First Horizon Pharmaceutical Corp. (FHRX) on Tuesday slashed its first-quarter outlook, citing the recent withdrawal of certain products and bloated wholesaler inventories of others, sending its shares sharply lower.
The company said it expects revenue of $11 million to $13 million, far below its previous expectations of $20 million to $25 million.
First Horizon projected earnings for the quarter would fall substantially below analysts` expectations. Four analysts polled by Thomson First Call estimated, on average, the company would post a break-even quarter.
The company said its decision to withdraw its Tanafed Suspension and Tanafed DM cold and allergy products to concentrate on newer Tanafed formulations, combined with the burn-off of excess inventories of other products, contributed to the revenue shortfall.
Shares of First Horizon fell 79 cents, or 23 percent, to $2.60 in morning trading on the Nasdaq, where it was one of the top percentage losers. The company`s stock has been as high as $27.10 in the past year, as generic competition for its medicines have hurt earnings.
The company said it will release first-quarter results on May 14.
mfg hugo
TUESDAY, APRIL 29, 2003 9:55 AM
- Reuters U.S. Company News
(Recasts lead, adds stock price, details)
NEW YORK, April 29 (Reuters) - First Horizon Pharmaceutical Corp. (FHRX) on Tuesday slashed its first-quarter outlook, citing the recent withdrawal of certain products and bloated wholesaler inventories of others, sending its shares sharply lower.
The company said it expects revenue of $11 million to $13 million, far below its previous expectations of $20 million to $25 million.
First Horizon projected earnings for the quarter would fall substantially below analysts` expectations. Four analysts polled by Thomson First Call estimated, on average, the company would post a break-even quarter.
The company said its decision to withdraw its Tanafed Suspension and Tanafed DM cold and allergy products to concentrate on newer Tanafed formulations, combined with the burn-off of excess inventories of other products, contributed to the revenue shortfall.
Shares of First Horizon fell 79 cents, or 23 percent, to $2.60 in morning trading on the Nasdaq, where it was one of the top percentage losers. The company`s stock has been as high as $27.10 in the past year, as generic competition for its medicines have hurt earnings.
The company said it will release first-quarter results on May 14.
mfg hugo
Danke!!!, kann ich diesen Bericht auch in Deutsch finden!
m.f.g.
m.f.g.
@FITTIBALDI
Vergleiche folgendes
MOVER(-): FHRX Expects Q1 Revs of $11 - $13M; Est $23M
Tuesday , April 29, 2003 10:19 ET
First Horizon Pharmaceutical Corporation (NasdaqNM: FHRX) announced that it expects to report Q1 2003 revenues between $11 - $13 million. The Company did not comment on what it expects to report for earnings (loss) per share pending completion of its accounting for its first quarter, although the Company did state that it expected earnings (loss) per share to be substantially below analysts` estimates. The company is to release operating results for the first quarter ended March 31, 2003 on May 14, 2003 after the market closes, and will host its first quarter 2003 call on May 14, 2003 at 5:00 p.m. eastern time.
Consensus Estimates
-Q1 2003 EPS: 0c (break-even)
-Q1 2003 Revenue: $23.04 million
Shares of FHRX are trading 24% lower in the session at this time on heavy volume.
Market Cap: 94.37M Avg Daily Vol: 653,300
JS200
Vergleiche folgendes
MOVER(-): FHRX Expects Q1 Revs of $11 - $13M; Est $23M
Tuesday , April 29, 2003 10:19 ET
First Horizon Pharmaceutical Corporation (NasdaqNM: FHRX) announced that it expects to report Q1 2003 revenues between $11 - $13 million. The Company did not comment on what it expects to report for earnings (loss) per share pending completion of its accounting for its first quarter, although the Company did state that it expected earnings (loss) per share to be substantially below analysts` estimates. The company is to release operating results for the first quarter ended March 31, 2003 on May 14, 2003 after the market closes, and will host its first quarter 2003 call on May 14, 2003 at 5:00 p.m. eastern time.
Consensus Estimates
-Q1 2003 EPS: 0c (break-even)
-Q1 2003 Revenue: $23.04 million
Shares of FHRX are trading 24% lower in the session at this time on heavy volume.
Market Cap: 94.37M Avg Daily Vol: 653,300
JS200
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
41 | ||
38 | ||
34 | ||
28 | ||
24 | ||
20 | ||
18 | ||
16 | ||
13 | ||
10 |
Wertpapier | Beiträge | |
---|---|---|
10 | ||
9 | ||
9 | ||
9 | ||
8 | ||
8 | ||
7 | ||
7 | ||
7 | ||
6 |